Melanocytic nevi frequently harbor oncogenic BRAF mutations and recently it was found that a subpopulation of melanocytes possess the ability to survive BRAF induced senescence, and suggest that p53 inactivation may promote malignant transformation of these cells [47] and thus have implications in skin cancer treatment. Here, BRAF is linked to skin cancer.